Join to view full profile
28 Center LnDelmar, NY 12054
Phone+1 518-391-3256
Dr. Inhaber is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
McGill University Faculty Medicine HospitalInternal Medicine, 1987 - 1991
McGill University Faculty of MedicineClass of 1987
Certifications & Licensure
NY State Medical License 1997 - 2027
Clinical Trials
- Efficacy and Safety of Prothromplex Total (Prothrombin Complex Concentrate) in Oral Anticoagulant Reversal Start of enrollment: 2010 Jul 09
Publications & Presentations
PubMed
- 6 citationsLong-term prophylaxis with lanadelumab for HAE: authorization for temporary use in France.Olivier Fain, Aurelie Du-Thanh, Delphine Gobert, David Launay, Neil Inhaber
Allergy, Asthma, and Clinical Immunology. 2022-04-01 - 59 citationsLong-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study.Aleena Banerji, Jonathan A. Bernstein, Douglas T. Johnston, William R. Lumry, Markus Magerl
Allergy. 2021-07-21 - 23 citationsA 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndromeCharles F. P. George, Neil T. Feldman, Yanping Zheng, Teresa L. Steininger, Susanna Grzeschik
Sleep & Breathing = Schlaf & Atmung. 2011-01-01
Press Mentions
Interim Phase 4 Data Support TAKHZYRO® (Lanadelumab) as an Effective Treatment to Reduce Attacks in Hereditary Angioedema PatientsFebruary 28th, 2022- Strong Phase III Results for Takhzyro in HAE Attack PreventionJune 8th, 2021
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
